Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Dermatology
•
Bullous/Blistering Skin Disorders
How often do you check desmoglien antibodies in pemphigus patients after treatment and during remission?
Related Questions
What is your stepwise approach to a patient with erosive gingivitis?
What JAK inhibitors (oral or topical) have you found most helpful in treating bullous pemphigoid?
What is your workup and management for patients with reactive perforating collagenosis?
How do you utilize JAK inhibitors in combination with other therapies to manage alopecia?
Would you offer adjuvant immunotherapy in an elderly patient with stage IIB desmoplastic melanoma post resection with underlying autoimmune disease?
What approaches can we take to initiate therapy and improve survival rates in patients with HLH?
Does your institution have formal policies or work flows to reduce unnecessary IGRAs ordered for patients on biologics?
What is your preferred topical retinoid for acne?
How have you incorporated biologics targeting the IL-36 pathway (e.g. Spevigo) into your treatment algorithm for psoriasis?
How do you approach longitudinal melanonychia of one fingernail in a pediatric patient?
